ArticleDiabetologia2008
Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.
A Fornoni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papercites it